This is from April on DORB ihub
Assunto: Cipan will launch a takeover to DOR BioPharma, Inc.
Enviada por:
Nome: José Escarigo
Data: 4/24/2007 3:55:18 PM
e-mail: escarigo@clix.pt
Respostas: Nenhuma
Questão:
Lisbon- Today a source from Cipan said that Cipan will launch a hostile takeover bid to DOR BioPharma, Inc.
Cipan, will notifie friday the Portuguese National Securities Market Commission (CNMV) that it was willing to waive the condition of a 75% minimum acceptance level to which its public offer for the acquisition of DOR BioPharma, Inc shares was subject, taking into consideration that the response received will be sufficient to develop the business project pursued through the takeover bid.
Cipan will launch a takeover bid for DOR BioPharma, Inc with the payment of $2.40 USD for each of the that responded to the tender offer, this initial offer could reach the limit of price of $2.55 USD for each share of the company.
About Cipan :
An understanding of the market, an embracing of ethical practices and the creation of novel technologies characterize the foundation of the Atral-Cipan Group.
The attributes have allowed the Group to develop distinct technological competencies with the creation of companies specializing in the production of raw materials for the pharmaceutical industry (Cipan) and finished pharmaceutical products (Atral), as well as the transfer of sophisticated chemical and pharmaceutical technologies (Prinmon).
Head Office/Factory:
P.O.Box 60
2601-906 CASTANHEIRA DO RIBATEJO
PORTUGAL
Phone: (+351) 263856800 - Fax: (+351) 263855020
email: adm@cipan.pt
Found the above info on yahoo message board....
